Jamieson Wellness (TSE:JWEL) Price Target Raised to C$42.00 at National Bankshares

Jamieson Wellness (TSE:JWEL) had its price objective raised by National Bankshares from C$36.50 to C$42.00 in a research report issued to clients and investors on Monday,BayStreet.CA reports. National Bankshares’ price target would suggest a potential upside of 14.04% from the stock’s previous close.

A number of other equities analysts also recently issued reports on JWEL. Canaccord Genuity Group increased their target price on Jamieson Wellness from C$32.50 to C$36.25 in a research note on Friday, August 9th. Royal Bank of Canada raised their price objective on Jamieson Wellness from C$37.00 to C$38.00 in a report on Friday, November 8th. TD Securities lifted their target price on Jamieson Wellness from C$40.00 to C$42.00 and gave the company a “buy” rating in a report on Friday, November 8th. Finally, BMO Capital Markets lifted their target price on Jamieson Wellness from C$35.00 to C$42.00 in a report on Friday, August 9th.

Jamieson Wellness Trading Up 2.6 %

Shares of JWEL stock traded up C$0.92 on Monday, hitting C$36.83. The stock had a trading volume of 28,325 shares, compared to its average volume of 60,409. The company has a debt-to-equity ratio of 92.76, a current ratio of 3.21 and a quick ratio of 1.08. The firm has a market capitalization of C$1.53 billion, a P/E ratio of 42.84 and a beta of 0.63. Jamieson Wellness has a 1 year low of C$23.98 and a 1 year high of C$36.98. The company’s 50 day moving average price is C$34.66 and its 200-day moving average price is C$31.28.

Insider Activity

In other Jamieson Wellness news, Director Michael Al Pilato sold 24,465 shares of the stock in a transaction on Friday, September 13th. The shares were sold at an average price of C$33.41, for a total transaction of C$817,380.54. Also, Senior Officer Regan Stewart sold 6,300 shares of the stock in a transaction on Friday, November 22nd. The stock was sold at an average price of C$35.69, for a total transaction of C$224,847.00. Insiders sold 32,402 shares of company stock worth $1,100,612 over the last quarter. Corporate insiders own 0.26% of the company’s stock.

Jamieson Wellness Company Profile

Jamieson Wellness Inc, together with its subsidiaries, develops, manufactures, distributes, markets, and sells of branded and customer branded health products for humans in Canada, the United States, China and internationally. It operates through two segments, Jamieson Brands and Strategic Partners. The Jamieson Brands segment manufactures, distributes, and markets branded natural health products including vitamins, minerals, and supplements.